- Investing.com
BioPorto A/S, an in-vitro diagnostics company, provides biomarker tools and antibodies for clinical research in Europe, North America, Asia, and internationally. It offers the neutrophil gelatinase-associated lipocalin test, a quantitative particle-enhanced turbidimetric immunoassay designed to run on automated clinical chemistry analyzers; monoclonal antibodies for scientific, pharmaceutical, and clinical research; and enzyme-linked immunosorbent assay kits, as well as generic rapid assay device for custom lateral flow assays. BioPorto A/S was incorporated in 1917 and is based in Hellerup, Denmark.
तुलना करने के लिए मीट्रिक्स | BIOPOR | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंधBIOPORपीअर्सक्षेत्र | |
---|---|---|---|---|
पी/ई अनुपात | −12.6x | −7.5x | −0.7x | |
PEG अनुपात | −0.55 | −0.01 | 0.00 | |
क़ीमत/बुक | 8.9x | 2.3x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 22.1x | 23.0x | 3.2x | |
अपसाइड (विश्लेषक लक्ष्य) | 66.9% | 130.8% | 47.0% | |
उचित मूल्य अपसाइड | अनलॉक करें | 2.8% | 7.5% | अनलॉक करें |